ISPE CEUs: 1.3
Type: Classroom Training Course
|14-15 May 2013||Indianapolis, Indiana||USA||Jeri Weigand|
|7-8 October 2013||New Brunswick, New Jersey||USA||Jeri Weigand|
|7-8 October 2013||Prague||Czech Republic||Lynn Bryan|
Auditing is a critical function within a pharmaceutical company. It provides management with information about how effectively the company controls the quality of their processes and products. Auditors must perform their jobs competently to ensure their company’s compliance with pharmaceutical USFDA GMP regulations and other quality standards like ICH Q10. Auditing for GMP is specifically designed to address the challenges of GMP auditing for the pharmaceutical industry and present the basic competencies required to effectively perform the auditor's assigned responsibilities and contribute to the improvement of auditor performance within a regulated industry.
Note: This course is not designed to prepare companies to be audited and does not contain content for medical device auditing.
This training course is of particular interest to existing and future members of the ISPE Process/Product Development (COP).
ISPE will provide continuing education units (ISPE CEUs) for all North American seminars and courses, including educational programming at the ISPE Annual Meeting. CEUs are nationally recognized units of achievement designed for those individuals continuing their education in their chosen field or profession.
Delegates attending European seminars and courses will receive a Certificate of Attendance, as ISPE CEUs are currently not offered at European events. Verification of CEUs is based on attendance as well as satisfactory completion of all evaluation materials. Statements of credit will be sent via email within four weeks of evaluation materials. One hour of education programming equals 0.1 ISPE CEU credits.